Document is current

Any future updates will be listed below

Evaluation of COVID-19 Incidence in Psoriatic Patients Receiving Adalimumab

Crossref DOI link: https://doi.org/10.30699/ijmm.17.3.324

Published Online: 2023-06-01

Update policy: https://doi.org/10.30699/crossmark

About CrossMark